Kayne Anderson Rudnick Investment Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-49
Closed -$854 1009
2024
Q4
$854 Hold
49
﹤0.01% 896
2024
Q3
$918 Hold
49
﹤0.01% 888
2024
Q2
$759 Hold
49
﹤0.01% 881
2024
Q1
$728 Hold
49
﹤0.01% 877
2023
Q4
$704 Buy
+49
New +$696 ﹤0.01% 865

Other funds holding SBRA

Kayne Anderson Rudnick Investment Management's SBRA Position: Q1 2025 in Review

Kayne Anderson Rudnick Investment Management sold out of Sabra Healthcare REIT (SBRA) in Q1 2025, closing a stake of 49 shares — an estimated $854 sold.

Kayne Anderson Rudnick Investment Management first reported a position in SBRA in Q4 2023 and held it in 5 quarters. The position peaked at $918 in Q3 2024. 403 funds tracked by Wall St. Rank hold SBRA as of Q1 2025.

  • Kayne Anderson Rudnick Investment Management reported no remaining Sabra Healthcare REIT position as of Q1 2025 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 49 Sabra Healthcare REIT shares in Q1 2025, an estimated $854.
  • Kayne Anderson Rudnick Investment Management first reported a position in Sabra Healthcare REIT in Q4 2023 and held it in 5 quarters.
  • Kayne Anderson Rudnick Investment Management's Sabra Healthcare REIT position peaked at $918 in Q3 2024.
  • 403 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2025.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2025, filed 14 May 2025.